Copied
 
 
Formål
Formål
Selskabets formål er at drive en virksomhed der udvikler og sælger et device der producerer fibrin dressing til brug for sårpleje og dermed beslægtet virksomhed.
Sidst opdateret den 09.02.2015 og angivet som gældende fra 07.01.2015 (3405 dage).
Ingen historik.
Status
Virksomhedsstatus
NORMAL.
Sidst opdateret den 09.02.2015 og angivet som gældende fra 04.02.2008 (5934 dage).
Ingen historik.
Branche
Branche
Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721900).
Sidst opdateret den 24.06.2008 og angivet som gældende fra 04.02.2008 (5934 dage).
Ingen historik.
Revision
Revisionfravalgt
false.
Sidst opdateret den 11.03.2015 og angivet som gældende fra 04.02.2008 (5934 dage).
Ingen historik.
Revisor
Revisor
EY Godkendt Revisionspartnerselskab
Sidst opdateret den 12.10.2018 og angivet som gældende fra 12.10.2018 (2031 dage).
Form
Virksomhedsform
60.
Sidst opdateret den 08.01.2019 og angivet som gældende fra 31.12.2018 (1951 dage).
HistorikStartStop
6031.12.2018
8004.02.200830.12.2018
Kontakt
Kontaktoplysninger
info@reapplix.com.
Sidst opdateret den 06.03.2019 og angivet som gældende fra 06.03.2019 (1886 dage).
HistorikStartStop
info@reapplix.com06.03.2019
britta@neholm.dk29.05.201605.03.2019
britta@meholm.dk04.02.200828.05.2016
Telefon
Telefonnummer
88168066.
Sidst opdateret den 17.10.2018 og angivet som gældende fra 17.10.2018 (2026 dage).
HistorikStartStop
8816806617.10.2018
4581196204.02.200816.10.2018
Navne
Binavne
Binavne
Leucotech A/S.
Sidst opdateret den 08.01.2019 og angivet som gældende fra 07.01.2019 (1944 dage).
HistorikStartStop
Leucotech A/S07.01.2019
LEUCOTECH ApS04.02.200806.01.2019
Tegningsregel
Tegningsregel
Selskabet tegnes af tre bestyrelsesmedlemmer eller af selskabets administrerende direktør og bestyrelsesformanden i forening.
Sidst opdateret den 09.02.2015 og angivet som gældende fra 07.01.2015 (3405 dage).
Fortolkning (2 tegningsmuligheder)
3 bestyrelsesmedlemmer
direktøren + formanden
Ingen historik.
Ansatte
04.05.2024
Kapital
04.05.2024
Fra årsrapport
Type af revisorbistand:Revisionspåtegning
Navn på revisionsvirksomhed:EY Godkendt Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:30700228
Beskrivelse af revisor:State Authorised Public Accountant
Virksomhedens regnskabsklasse:Regnskabsklasse B
Grundlag for konklusion (revision):Basis for opinionWe conducted our audit in accordance with International Standards on Auditing (ISAs) and additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the "Auditor's responsibilities for the audit of the consolidated financial statements and the parent company financial statements" (hereinafter collectively referred to as "the financial statements") section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):OpinionWe have audited the consolidated financial statements and the parent company financial statements of Reapplix A/S for the financial year 1 January – 31 December 2022, which comprise income statement, statement of comprehensive income, balance sheet, statement of changes in equity, cash flow statement and notes, including accounting policies, for the Group and the Parent Company. The consolidated financial statements and the parent company financial statements are prepared in accordance with International Financial Reporting Standards as adopted by the EU and additional requirements of the Danish Financial Statements Act. In our opinion, the consolidated financial statements and the parent company financial statements give a true and fair view of the financial position of the Group and the Parent Company at 31 December 2022 and of the results of the Group's and the Parent Company's operations and cash flows for the financial year 1 January – 31 December 2022 in accordance with International Financial Reporting Standards as adopted by the EU and additional requirements of the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on the Management’s reviewManagement is responsible for the Management's review. Our opinion on the financial statements døs not cover the Management's review, and we do not express any assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the Management's review provides the information required under the Danish Financial Statements Act. Based on our procedures, we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement of the Management's review.
Bibranche
Ingen nuværende registrering.
Ingen historik.
Børsnoteret
04.05.2024
Ingen nuværende registrering.
Ingen historik.
Hjemmeside
04.05.2024
Ingen nuværende registrering.
Ingen historik.